A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III Non-small Cell Lung Cancer
Clinical trial NCT04111913 · UNKNOWN
Trial details
- NCT number
- NCT04111913
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2020-08-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.